 
     |
| 'Spike-Direct' . . . Novavax Covid vaccine has its own twist, vs Pfizer, Moderna, J&J (Page 1/2) |
|
rinselberg
|
JUN 14, 11:48 AM
|
|
"Novavax Covid vaccine highly effective in U.S. trials, including against variants, company says"
| quote | | . . . plans to apply to [FDA] for emergency use authorization in the third quarter. |
|
| quote | . . . The Novavax vaccine differs slightly from the other vaccines in use. The Pfizer, Moderna and Johnson & Johnson vaccines all work by providing genetic instructions for the body to build the coronavirus's spike protein, which the immune system learns to recognize and fight. The Novavax shot skips the instructions and delivers the spike protein directly to the body.
Many well-known vaccines use a similar approach — delivering a specific part of the pathogen to the body to learn to recognize — including the hepatitis B vaccine, the HPV vaccine and the shingles vaccine. The Novavax vaccine can be stored in standard refrigerator temperatures. . . .
|
|
- Novavax is a Maryland-based biotech company
- Solid safety and efficacy results from U.S. Phase 3 trial
- Two shots, 21-days apart, "Pfizer-style"
- Novavax CEO eyes a "booster vaccine" role in the U.S., filling out a lineup that already includes the Pfizer, Modern and Johnson & Johnson vaccines.
Sara G. Miller and Erika Edwards for NBC News; June 14, 2021.
https://www.nbcnews.com/hea...ing-against-n1270613[This message has been edited by rinselberg (edited 06-14-2021).]
|
|
|
|
maryjane
|
JUN 14, 02:18 PM
|
|
They're kinda like Boeing and Blue Origin are to SpaceX.
By the time the trial is over and approval for Novavax gets here, the other vaccines will have already done what was needed.
better late than never... maybe India will buy some.
|
|
|
|
2.5
|
JUN 14, 02:38 PM
|
|
| quote | Originally posted by maryjane:
They're kinda like Boeing and Blue Origin are to SpaceX.
By the time the trial is over and approval for Novavax gets here, the other vaccines will have already done what was needed.
better late than never... maybe India will buy some. |
|
I thought they said we'd need yearly ones though.
|
|
|
|
maryjane
|
JUN 14, 05:02 PM
|
|
|
I thought they said we'd all be dead in a few months if we got the shots...
|
|
|
|
TheDigitalAlchemist
|
JUN 14, 05:48 PM
|
|
|
I thought you said I was alright Spider...
|
|
|
|
rinselberg
|
JUN 14, 06:09 PM
|
|
|
|
cliffw
|
JUN 15, 10:53 AM
|
|
|
|
|
Jake_Dragon
|
JUN 15, 11:21 AM
|
|
|
I thought it was about saving lives and not making and ass load of money.
|
|
|
|
rinselberg
|
JUN 15, 12:25 PM
|
|
"[Instagram] post overstates study’s ‘200%’ finding on hydroxychloroquine’s power vs COVID-19"
Tom Kertscher for PolitiFact; June 14, 2021.
https://www.politifact.com/...ing-hydroxychloroqu/
| quote | Three experts who spoke to PolitiFact were critical of the study.
Joel Farley, a University of Minnesota College of Pharmacy professor, noted that the study was designed not to test the effectiveness of the two drugs, but rather as an observational study that basically looks at survival and then models what things might have predicted survival.
"The concern is that this poorly designed study might influence" prescribing of the two drugs "when the overwhelming body of evidence has shown it has no benefit for treating COVID," Farley said.
Dr. Neil Schluger, professor of medicine, epidemiology and environmental health science at Columbia University, said that to conclude cause-and-effect "is an obvious error," calling the study very small with little hard data. "It’s likely that patients who died rapidly received less total (of the two drugs) because they were dead; one can’t conclude from these data that they died because they got fewer doses. It’s also likely that if they received lower doses on a daily basis, it’s because they were sicker to begin with," he said.
Ally Dering-Anderson, a professor at the University of Nebraska College of Pharmacy, said pairing hydroxychloroquine with azithromycin to treat a virus raises serious questions because azithromycin is a traditional antibacterial drug that doesn’t treat viruses and hydroxychloroquine has no known benefit in treating the SARS-CoV-2 virus. "There is no pharmacologically sound reason to believe that combining two drugs that don’t work will suddenly result in therapy that does work," she said.
Hydroxychloroquine is not approved in the U.S. for COVID-19. The FDA recommends against the use of hydroxychloroquine with or without azithromycin for treating COVID-19 patients. The World Health Organization recommends against using hydroxychloroquine to prevent or to treat COVID-19 infection. |
|
 [This message has been edited by rinselberg (edited 06-15-2021).]
|
|
|
|
rinselberg
|
JUN 15, 01:31 PM
|
|
| quote | Originally posted by Jake_Dragon:
I thought it was about saving lives and not making and ass load of money. |
|
Not sure what that's about. Suspicious of why there is such a number of "players" that are each marketing their version of a Covid vaccine? Instead of just 2 or 3 different Covid vaccines and vaccine developers?[This message has been edited by rinselberg (edited 06-15-2021).]
|
|
|
|